Literature DB >> 2688299

Generation and characterization of monoclonal antibodies reactive with the 49-kDa proteinase of tobacco etch virus.

D E Slade1, R E Johnston, W G Dougherty.   

Abstract

Monoclonal antibodies (McAbs) were generated against two tobacco etch virus (TEV)-encoded nonstructural proteins, the 49-kilodalton (kDa) proteinase and the 58-kDa putative RNA-dependent RNA polymerase. This process was facilitated by the fact that these two TEV nonstructural proteins cocrystallize in the nuclei of virus-infected cells to form nuclear inclusion (NI) bodies which can be purified readily. The anti-NI McAbs were shown by Western blot analysis to be specific for either the TEV 49-kDa or the 58-kDa protein. Those McAbs reactive with the 49-kDa proteinase were characterized further with respect to the 49-kDa domain with which they reacted and with respect to their ability to inhibit the autocatalytic or self-processing activity of the 49-kDa proteinase. The 49-kDa antigens were synthesized from a TEV cDNA sequence using cell-free transcription and translation systems. Each anti-49-kDa McAb was used in immunoprecipitation studies with a series of 49-kDa antigens which represented a nested set of 49-kDa proteins with common amino termini but varying in length. Immunoprecipitation results showed that all of the anti-49-kDa proteinase McAbs reacted with one of five binding regions, designated A through E from the carboxy terminus of the proteinase, which were 77, 38, 81, 18, and 61 amino acids long, respectively. The 38-amino-acid binding region B contained the proposed catalytic cysteine 339 residue and was recognized by only one McAb, 4911. McAb 4911 was the only anti-49-kDa McAb capable of inhibiting the self-processing reaction in which the 49-kDa proteinase is released from its 75-kDa polyprotein precursor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2688299     DOI: 10.1016/0042-6822(89)90562-x

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Viral RNA silencing suppressors inhibit the microRNA pathway at an intermediate step.

Authors:  Elisabeth J Chapman; Alexey I Prokhnevsky; Kodetham Gopinath; Valerian V Dolja; James C Carrington
Journal:  Genes Dev       Date:  2004-05-06       Impact factor: 11.361

2.  Analysis of the VPg-proteinase (NIa) encoded by tobacco etch potyvirus: effects of mutations on subcellular transport, proteolytic processing, and genome amplification.

Authors:  M C Schaad; R Haldeman-Cahill; S Cronin; J C Carrington
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

3.  Roles of the sequence encoding tobacco etch virus capsid protein in genome amplification: requirements for the translation process and a cis-active element.

Authors:  S Mahajan; V V Dolja; J C Carrington
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

4.  A conformational change in Sindbis virus glycoproteins E1 and E2 is detected at the plasma membrane as a consequence of early virus-cell interaction.

Authors:  D C Flynn; W J Meyer; J M Mackenzie; R E Johnston
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

5.  Functions of the tobacco etch virus RNA polymerase (NIb): subcellular transport and protein-protein interaction with VPg/proteinase (NIa).

Authors:  X H Li; P Valdez; R E Olvera; J C Carrington
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

6.  Functional analysis of the interaction between VPg-proteinase (NIa) and RNA polymerase (NIb) of tobacco etch potyvirus, using conditional and suppressor mutants.

Authors:  J A Daròs; M C Schaad; J C Carrington
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

7.  Structural rearrangement of infecting Sindbis virions at the cell surface: mapping of newly accessible epitopes.

Authors:  W J Meyer; R E Johnston
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

8.  Conformational alteration of Sindbis virion glycoproteins induced by heat, reducing agents, or low pH.

Authors:  W J Meyer; S Gidwitz; V K Ayers; R J Schoepp; R E Johnston
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.